Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(17%)
Results Posted
75%(3 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_3
5
83%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
5(83.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (83.3%)
Phase 41 (16.7%)

Trials by Status

terminated117%
completed467%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

NCT05633810
completedphase_3

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

NCT01776424
completedphase_3

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

NCT02325466
terminatedphase_3

A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke

NCT02072226
completedphase_4

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

NCT00947843
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05633810Phase 3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Recruiting
NCT01776424Phase 3

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Completed
NCT02325466Phase 3

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

Completed
NCT02072226Phase 3

A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke

Terminated
NCT00947843Phase 4

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Completed
NCT00027066Phase 3

Warfarin Versus Aspirin Recurrent Stroke Study

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6